Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07328516 | Natural History Study of Early Life Exposures in Agriculture (ELEA) | enrolling by invitation | — | 64,277 | National Cancer Institute (NCI)NIH | 1 | Sep 29, 2026 | clinicaltrials |
| NCT00068003 | Harvesting Cells for Experimental Cancer Treatments | enrolling by invitation | — | 7,000 | National Cancer Institute (NCI)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT03762733 | Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies | enrolling by invitation | — | 500 | National Cancer Institute (NCI)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT07832396 | Community Study to Increase Mammogram Screening Among Overdue Women(IMPLEMENT) | enrolling by invitation | N/A | 15,000 | National University Hospital, SingaporeOTHER | 1 | Sep 22, 2026 | clinicaltrials |
| NCT05645536 | Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study | enrolling by invitation | Phase 3 | 250 | Tolmar Inc.INDUSTRY | 6 | Sep 1, 2026 | clinicaltrials |
| NCT07798466 | Immediate Autologous Tissue Breast Reconstruction and Radiotherapy Strategy After Breast Cancer Surgery | enrolling by invitation | — | 128 | Fudan UniversityOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT07784660 | Molecular Imaging of EpCam Expression in Breast Cancer Using [99mTc]Tc-DARPinEc1-G3C(EpCam-Scan) | enrolling by invitation | Phase 1 | 10 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT06910072 | Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer（UPGRADE-TNBC）(UPGRADE-TNBC) | enrolling by invitation | Phase 2 / Phase 3 | 32 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 18, 2026 | clinicaltrials |
| NCT06680596 | Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy(SAFIR3LibHERty) | enrolling by invitation | Phase 2 | 80 | UNICANCEROTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07275463 | [99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression | enrolling by invitation | Phase 2 | 40 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07292571 | Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107 | enrolling by invitation | Phase 2 | 50 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07651345 | Trial to Evaluate the Impact of Various Pragmatic Interventions to Increase Mammography Uptake Among Defaulted Repeat Screeners in Singapore(REMIND1) | enrolling by invitation | N/A | 12,750 | National University Hospital, SingaporeOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07644845 | MammoVerse: Clinicians Focus Group | enrolling by invitation | — | 12 | University of Central FloridaOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT07218003 | A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 | enrolling by invitation | Phase 1 | 149 | Rondo TherapeuticsINDUSTRY | 1 | Jun 11, 2026 | clinicaltrials |
| NCT06924788 | Video-Conferenced Stress Management and Relaxation Training (VSMART) For Alabama Breast Cancer Survivors(VSMART) | enrolling by invitation | N/A | 25 | University of Alabama at BirminghamOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT06885424 | A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products(DESCENT-1) | enrolling by invitation | — | 400 | A2 Biotherapeutics Inc.INDUSTRY | 1 | May 20, 2026 | clinicaltrials |
| NCT07298980 | ExBRAC- Expressive Writing in Breast Cancer(ExBRAC) | enrolling by invitation | N/A | 272 | Region SkaneOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT05486520 | Low-field MRI for Breast Cancer Screening | enrolling by invitation | N/A | 40 | Massachusetts General HospitalOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT05400941 | Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care | enrolling by invitation | N/A | 910 | Rutgers, The State University of New JerseyOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT07549685 | Music Therapy in Patients With Breast Cancer (IMPACT)(IMPACT-) | enrolling by invitation | N/A | 24 | Istituto di Studi Superiori Musicali (ISSM) Conservatorio Antonio Vivaldi di AlessandriaOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT05876390 | Impact of Regional Anesthesia on Chronic Post-operative Pain(IRACPoP) | enrolling by invitation | — | 1,500 | Niguarda HospitalOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT07514728 | Concept-verification Clinical Trial on the Inhibition of Breast Cancer Lung Metastasis Progression by Hyperbaric Oxygen(HBOIBCLM) | enrolling by invitation | N/A | 10 | Jinan Central HospitalOTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT07483034 | Receptive Music Therapy Effects on Anxiety, Depression, QoL, and EGF, IL-8, and NfL During the Breast Cancer Treatment. | enrolling by invitation | N/A | 90 | Brigita VilcOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT06650748 | Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast Cancer(NeoMARS) | enrolling by invitation | Phase 2 | 100 | Peking UniversityOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT07465497 | Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer | enrolling by invitation | N/A | 80 | Instituto Jalisciense de CancerologiaOTHER_GOV | 1 | Mar 12, 2026 | clinicaltrials |
| NCT05160480 | A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG | enrolling by invitation | — | 9 | University of California, DavisOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT07080463 | Application of VascuLens 2.0, A Mixed Reality System for Surgical Guidance During DIEP Flap Harvest(VascuLens RCT) | enrolling by invitation | Phase 1 | 60 | University of British ColumbiaOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT07049822 | Optimising Mammography Screening Accuracy With Blood-based Biomarkers(OPTIMA) | enrolling by invitation | — | 1,200 | Vejle HospitalOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT04996316 | MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals | enrolling by invitation | — | 1,141 | OHSU Knight Cancer InstituteOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT07409298 | Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy | enrolling by invitation | N/A | 300 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT01173341 | Cardiotoxicity of Cancer Therapy (CCT) | enrolling by invitation | — | 700 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT06332131 | Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature | enrolling by invitation | — | 25 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT07376629 | A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC | enrolling by invitation | Phase 2 | 60 | Huabo Biopharm Co., Ltd.INDUSTRY | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07376681 | Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health | enrolling by invitation | — | 2,000 | Taizhou HospitalOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07359404 | Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC | enrolling by invitation | Phase 2 | 60 | YING FANOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT07352137 | Endoscopic Nipple-Sparing Mastectomy (E-NSM) With Immediate Multistage Autologous Fat Grafting(IMAFG) for Total Breast Reconstruction Via the Axillary Incision | enrolling by invitation | N/A | 20 | Guangdong Provincial Hospital of Traditional Chinese MedicineOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT07283107 | Trial to Evaluate the Impact of Various Behavioural Interventions to Increase Mammography Uptake Among Singaporean Women(PROMPT) | enrolling by invitation | N/A | 8,910 | National University Hospital, SingaporeOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07306130 | Consensus on Skin Care in Breast Cancer Patients | enrolling by invitation | — | 15 | Venus Research CenterOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07100054 | Pharmacogenomic and Circulating Biomarkers for CDK4/6 Inhibitors | enrolling by invitation | — | 100 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Dec 12, 2025 | clinicaltrials |
| NCT06843681 | Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study | enrolling by invitation | Phase 2 | 54 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT07206888 | Advanced Ultrasound Signal Processing of Suspicious Breast Images(AUSPICIOUS) | enrolling by invitation | — | 252 | Johns Hopkins UniversityOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT07151963 | Effects of Prolonged Continuous Theta Burst Stimulation in Chemotherapy-induced Peripheral Neuropathy(CIPN) | enrolling by invitation | N/A | 40 | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT07140107 | Effectiveness of Original vs. AI-Generated Plain Language Summaries of Systematic Reviews | enrolling by invitation | N/A | 130 | University of Split, School of MedicineOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT07030231 | Use of Intraoperative Radiotherapy in Breast Cancer(RIOMA) | enrolling by invitation | — | 3,000 | Parc de Salut MarOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT06391749 | Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)(K-ACCELERATE) | enrolling by invitation | — | 1,000 | Gene SolutionsINDUSTRY | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07056205 | Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer. | enrolling by invitation | — | 100 | Sohag UniversityOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT07023848 | PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors | enrolling by invitation | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07023861 | The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies | enrolling by invitation | Early Phase 1 | 20 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT06986213 | Heart Pillow - Chemoteraphy(Hepi_Qt) | enrolling by invitation | N/A | 60 | José Manuel Afonso MoreiraOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT06958445 | Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy(SAFE) | enrolling by invitation | Phase 2 | 90 | Taipei City HospitalOTHER_GOV | 1 | May 6, 2025 | clinicaltrials |
Data updated 21 hours agoSource updated Sep 29, 2026source: clinicaltrials